xufeng chen
@xufeng_chen
Assistant professor at the department of Hematopoietic Biology and Malignancy at MD Anderson Cancer Center. Hematologic oncologist, Cancer immunologist.
ID: 955268175603617792
https://scholar.google.com/citations?hl=en&user=wvjIV3EAAAAJ 22-01-2018 02:37:35
50 Tweet
191 Followers
194 Following
Now in Cancer Discovery: #Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid #Leukemia - Christina Glytsou xufeng chen Emmanouil Zacharioudakis Evris Gavathiotis Iannis Aifantis et al. Rutgers Cancer Institute ME Cancer Center Albert Einstein College of Medicine - Official Perlmutter Cancer Center at NYU Langone Health NYU GSOM Pathology doi.org/10.1158/2159-8…
Our second story on BH3 mimetic resistance in AML is now out at Cancer Discovery! Check it out! aacrjournals.org/cancerdiscover…
Oncogene specificity influences immune response in acute myeloid leukemia. nature.com/articles/s4146… Steve Lane Megan Bywater Rebecca Austin Jasmin Straube @QIMRBerghofer Iannis Aifantis
A very nice review on AML in older adults in the ASCO education book by Dr. Catherine Lai Rahul Bhansali, MD Richard J. Lin MD PhD et al! #leusm ascopubs.org/doi/full/10.12…
Preclinical findings of a study from Iannis Aifantis and xufeng chen reveal mitophagy to be a key mechanism of BH3 mimetic resistance in patients with acute myeloid leukemia, marking a new target within the disease. Read more ⤵️ bit.ly/3M9mvkh
Out today Cell our latest work on peptide:MHC class I expression & degradation and the discovery of a novel protein complex potentially important for T cell recognition in cancer. A great collaboration with Jun Wang NYU Grossman School of Medicine #Immunotherapy cell.com/cell/fulltext/…
It was great collaboration with Iannis Aifantis #nyu #nyulangone. This is also the first article on I/O from my young lab. Many thanks to michele pagano, Peter Cresswell Yale Department of Immunobiology, Patricia Dahia and Eureka Therapeutics! Congratulations to talented postdoc xufeng chen Qiao Lu !!
Read Cancer Discovery's #ResearchWatch: A Cell-Surface MHC-I Inhibitory Axis Promotes Immune Evasion in Cancer, a summary of the paper by xufeng chen, Qiao Lu, Iannis Aifantis, Jun Wang et al. bit.ly/3P4v9lx NYU Grossman School of Medicine
In partnership with The Mark Foundation for Cancer Research, our NYU GSOM Pathology investigators have identified a trimolecular complex that may yield new strategies to improve checkpoint inhibitor efficacy in AML. Learn more from co-authors Iannis Aifantis, Jun Wang & @Xufeng_Chen: bit.ly/3NxrbAI
The Chen lab is now up and running at MD Anderson Cancer Center 🎉 🥳 A huge thank you to Iannis Aifantis for all the support throughout my journey! Many thanks to Jun Wang as well👏🏻 PS: We are actively hiring motivated scientists to innovate cancer immunotherapy🤝🏻
